Phocas Financial’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
Phocas Financial's ADMA Position: Q2 2026 in Review
Phocas Financial sold out of ADMA Biologics (ADMA) in Q2 2026, closing a stake of 97,942 shares — an estimated $882K sold.
Phocas Financial first reported a position in ADMA in Q1 2026 and held it in 1 quarter. The position peaked at $882K in Q1 2026. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.
- Phocas Financial reported no remaining ADMA Biologics position as of Q2 2026 after selling out during the quarter.
- Phocas Financial sold 97,942 ADMA Biologics shares in Q2 2026, an estimated $882K.
- Phocas Financial first reported a position in ADMA Biologics in Q1 2026 and held it in 1 quarter.
- Phocas Financial's ADMA Biologics position peaked at $882K in Q1 2026.
- 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.
Based on Phocas Financial's 13F filing for Q2 2026, filed 31 Jul 2026.